Evidence map›Paper›PMID 36519817›Full record

ArticleJournal of the National Cancer Institute. Monographs2022

Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials.

Karlynn BrintzenhofeSzoc, Beverly Canin, Esmeralda Casas-Silva, Andrea Denicoff, Christa Braun-Inglis, Izumi Okado, Alexis Bakos

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the National Cancer Institute. Monographs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Karlynn BrintzenhofeSzocDr. Renato LaRocca Endowed Chair in Oncology Social Work, Kent School of Social Work, University of Louisville, Louisville, KY, USA.ORCID 0000-0001-9004-8398
Beverly CaninSCOREboard Patient Advocate Board, The Cancer and Aging Research Group, USA.
Esmeralda Casas-SilvaCenter for Biomedical Informatics and Information Technology, Informatics and Data Science Program, National Institutes of Health, National Cancer Institute, Rockville, MD, USA.
Andrea DenicoffDivision of Cancer Treatment and Diagnosis, Cancer Therapy and Evaluation Program, National Institutes of Health, National Cancer Institute, Rockville, MD, USA.
Christa Braun-InglisClinical Faculty, UH Nancy Atmospera-Walch School of Nursing, University of Hawaii Cancer Center/Hawaii M/U NCORP, Honolulu, HI, USA.
Izumi OkadoUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Alexis BakosDivision of Cancer Prevention, Community Oncology and Prevention Trials Research Group, National Institutes of Health, National Cancer Institute, Rockville, MD, USA.
National Institutes of Health · USUniversity of Hawaiʻi at Mānoa · USPatient Advocate Foundation · USUniversity of Louisville · US

Funding

The Hawaii NCORPUG1CA189804 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Jared Acoba, Jeffrey Lee Berenberg · 2014 to 2026
$15.7M
NCI NIH HHS UG1 CA189804
6 · The paper itself

Abstract

The workshop "Engaging Older Adults in Cancer Clinical Trials Conducted in the NCI Clinical Trials Network: Challenges and Opportunities" included a Patient Stakeholder Workgroup that explored the needs and concerns of older adults with cancer regarding clinical trials. To accomplish this, the workgroup conducted patient focus groups in which participants were interviewed, recorded conversations were analyzed and coded, and salient themes were identified. The focus groups identified general barriers to accrual such as complex consent forms, general communication, restrictive eligibility, nonreferrals, patient costs, cultural insensitivity, limited accessibility in community settings, and transportation issues. They also identified the influence of knowledgeable information presenters, improved care, family or caregiver support, and the desire to help others as drivers or reasons to participate in clinical trials. The workshop concluded that multi-level interventions could be used to increase the accrual of older adults to National Cancer Institute clinical trials as well as others.

Indexed as

Clinical Trials as TopicNeoplasmsPatient SelectionAgedFocus GroupsHumansNational Cancer Institute (U.S.)United States

Identifiers

PMID36519817
PMCPMC9949584
OpenAlexW4311807764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.